Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases

Nature Communications

Volumn 7, Issue , 2016, Pages

  Walport, Louise J ^a   Hopkinson, Richard J ^a   Chowdhury, Rasheduzzaman ^a   Schiller, Rachel ^a   Ge, Wei ^a   Kawamura, Akane ^a,b   Schofield, Christopher J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HISTONE DEMETHYLASE; HISTONE H3; HISTONE N EPSILON METHYLLYSINE DEMETHYLASE; LYSINE; N OMEGA METHYLARGININE DEMETHYLASE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

CATALYSIS; ENZYME ACTIVITY; FORMALDEHYDE; METHYLATION; OXIDATION; OXYGEN; PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DEMETHYLATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; ANIMAL; BINDING SITE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; SF9 CELL LINE;

ANIMALS; ARGININE; BINDING SITES; DEMETHYLATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MODELS, MOLECULAR; PROTEIN CONFORMATION; SF9 CELLS;

EID: 84975735395     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11974     Document Type: Article

References (70)

1. Walsh, C. T., Garneau-Tsodikova, S. & Gatto, Jr G. J. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl. 44, 7342-7372 (2005).
2. Rothbart, S. B. & Strahl, B. D. Interpreting the language of histone and DNA modifications. Biochim. Biophys. Acta 1839, 627-643 (2014).
3. Le, D. D. & Fujimori, D. G. Protein and nucleic acid methylating enzymes: mechanisms and regulation. Curr. Opin. Chem. Biol. 16, 507-515 (2012).
4. Walport, L. J., Hopkinson, R. J. & Schofield, C. J. Mechanisms of human histone and nucleic acid demethylases. Curr. Opin. Chem. Biol. 16, 525-534 (2012).
5. Di Lorenzo, A. & Bedford, M. T. Histone arginine methylation. FEBS Lett. 585, 2024-2031 (2011).
6. Zhang, X. et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor alpha target gene activation. Proc. Natl Acad. Sci. USA 109, 13331-13336 (2012).
7. Wang, Y. et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279-283 (2004).
8. Thompson, P. R. & Fast, W. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? ACS Chem. Biol. 1, 433-441 (2006).
9. Chang, B., Chen, Y., Zhao, Y. & Bruick, R. K. JMJD6 is a histone arginine demethylase. Science 318, 444-447 (2007).
10. Webby, C. J. et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 325, 90-93 (2009).
11. Han, G. et al. The hydroxylation activity of Jmjd6 is required for its homooligomerization. J. Cell. Biochem. 113, 1663-1670 (2012).
12. Mantri, M. et al. The 2-Oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues. Chem Bio Chem 12, 531-534 (2011).
13. Gao, W. W. et al. Arginine methylation of HSP70 regulates retinoid acidmediated RARbeta2 gene activation. Proc. Natl Acad. Sci. USA 112, E3327-E3336 (2015).
14. Lawrence, P., Conderino, J. S. & Rieder, E. Redistribution of demethylated RNA helicase A during foot-and-mouth disease virus infection: role of Jumonji C-domain containing protein 6 in RHA demethylation. Virology 452-453, 1-11 (2014).
15. Poulard, C., Rambaud, J., Hussein, N., Corbo, L. & Le Romancer, M. JMJD6 regulates ERalpha methylation on arginine. PLoS ONE 9, e87982 (2014).
16. Liu, W. et al. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell 155, 1581-1595 (2013).
17. Bottger, A., Islam, M. S., Chowdhury, R., Schofield, C. J. & Wolf, A. The oxygenase Jmjd6-a case study in conflicting assignments. Biochem. J. 468, 191-202 (2015).
18. Markolovic, S., Wilkins, S. E. & Schofield, C. J. Protein hydroxylation catalyzed by 2-oxoglutarate-dependent oxygenases. J. Biol. Chem. 290, 20712-20722 (2015).
19. Hopkinson, R. J. et al. Is JmjC oxygenase catalysis limited to demethylation? Angew. Chem. Int. Ed. Engl. 52, 7709-7713 (2013).
20. Williams, S. T. et al. Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates. Epigenetics 9, 1596-1603 (2014).
21. Klose, R. J., Kallin, E. M. & Zhang, Y. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7, 715-727 (2006).
22. Hopkinson, R. J., Hamed, R. B., Rose, N. R., Claridge, T. D. & Schofield, C. J. Monitoring the activity of 2-oxoglutarate dependent histone demethylases by NMR spectroscopy: direct observation of formaldehyde. Chem Bio Chem 11, 506-510 (2010).
23. Sakurai, M. et al. A miniaturized screen for inhibitors of Jumonji histone demethylases. Mol. Biosyst. 6, 357-364 (2010).
24. Feng, W., Yonezawa, M., Jung, Y., Jenuwein, T. & Grummt, I. PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation. Nat. Struct. Mol. Biol. 17, 445-450 (2010).
25. Yamane, K. et al. JHDM2A, a JmjC-Containing H3K9 Demethylase, Facilitates Transcription Activation by Androgen Receptor. Cell 125, 483-495 (2006).
26. Hopkinson, R. J. et al. 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation. Chemical Science 4, 3110-3117 (2013).
27. Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404-408 (2012).
28. Couture, J. F., Collazo, E., Ortiz-Tello, P. A., Brunzelle, J. S. & Trievel, R. C. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat. Struct. Mol. Biol. 14, 689-695 (2007).
29. Chen, Z. et al. Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc. Natl Acad. Sci. USA 104, 10818-10823 (2007).
30. Ng, S. S. et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448, 87-91 (2007).
31. Bedford, M. T. & Clarke, S. G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33, 1-13 (2009).
32. Plank, M. et al. Expanding the yeast protein arginine methylome. Proteomics 15, 3232-3243 (2015).
33. Zhang, X., Wen, H. & Shi, X. Lysine methylation: beyond histones. Acta Biochim. Biophys. Sin. 44, 14-27 (2012).
34. Ponnaluri, V. K., Vavilala, D. T., Putty, S., Gutheil, W. G. & Mukherji, M. Identification of non-histone substrates for JMJD2A-C histone demethylases. Biochem. Biophys. Res. Commun. 390, 280-284 (2009).
35. Lu, T. et al. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc. Natl Acad. Sci. USA 107, 46-51 (2010).
36. Sola, S. et al. p53 interaction with JMJD3 results in its nuclear distribution during mouse neural stem cell differentiation. PLoS ONE 6, e18421 (2011).
37. Ambler, R. P. & Rees, M. W. Epsilon-N-Methyl-lysine in bacterial flagellar protein. Nature 184, 56-57 (1959).
38. Lanouette, S., Mongeon, V., Figeys, D. & Couture, J. F. The functional diversity of protein lysine methylation. Mol. Syst. Biol. 10, 724 (2014).
39. Moore, K. E. & Gozani, O. An unexpected journey: lysine methylation across the proteome. Biochim. Biophys. Acta 1839, 1395-1403 (2014).
40. Kudithipudi, S., Kusevic, D., Weirich, S. & Jeltsch, A. Specificity analysis of protein lysine methyltransferases using SPOT peptide arrays. J. Vis. Exp. e52203 (2014).
41. Paik, W. K. & Kim, S. Enzymatic demethylation of calf thymus histones. Biochem. Biophys. Res. Commun. 51, 781-788 (1973).
42. Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (2004).
43. Whetstine, J. R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467-481 (2006).
44. Tsukada, Y. et al. Histone demethylation by a family of JmjC domaincontaining proteins. Nature 439, 811-816 (2006).
45. Hahn, P. et al. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation. PLoS ONE 5, e13769 (2010).
46. Unoki, M. et al. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6). J. Biol. Chem. 288, 6053-6062 (2013).
47. Sinha, K. M., Yasuda, H., Coombes, M. M., Dent, S. Y. R. & de Crombrugghe, B. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J. 29, 68-79 (2010).
48. Ishimura, A. et al. Jmjd5, an H3K36 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development 139, 749-759 (2012).
49. Liu, L. et al. Hairless is a histone H3K9 demethylase. FASEB J. 28, 1534-1542 (2014).
50. Carlson, S. M. & Gozani, O. Emerging technologies to map the protein methylome. J. Mol. Biol. 426, 3350-3362 (2014).
51. Guo, A. et al. Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol. Cell. Proteomics 13, 372-387 (2014).
52. Bremang, M. et al. Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. Mol. Biosyst. 9, 2231-2247 (2013).
53. Yang, M. et al. Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor. J. Biol. Chem. 286, 7648-7660 (2011).
54. Hillringhaus, L. et al. Structural and evolutionary basis for the dual substrate electivity of the human KDM4 histone demethylase family. J. Biol. Chem. 286, 41616-41625 (2011).
55. Ehrismann, D. et al. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem. J. 401, 227-234 (2007).
56. Johansson, C. et al. The roles of Jumonji-type oxygenases in human disease. Epigenomics 6, 89-120 (2014).
57. Greer, E. L. & Shi, Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357 (2012).
58. Helin, K. & Dhanak, D. Chromatin proteins and modifications as drug targets. Nature 502, 480-488 (2013).
59. Bosetti, C., McLaughlin, C., Tarone, R. E., Pira, E. & La Vecchia, C. Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006. Ann. Oncol. 19, 29-43 (2008).
60. Rotili, D. et al. A photoreactive small-molecule probe for 2-oxoglutarate oxygenases. Chem. Biol. 18, 642-654 (2011).
61. Rose, N. R. et al. Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J. Med. Chem. 51, 7053-7056 (2008).
62. Rose, N. R. et al. Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases. J. Med. Chem. 55, 6639-6643 (2012).
63. Loenarz, C. et al. PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nepsilon-dimethyl lysine demethylase. Hum. Mol. Genet. 19, 217-222 (2010).
64. Hwang, T. L. & Shaka, A. J. Water suppression that works. excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. 112, 275-279 (1995).
65. Otwinowski, Z. & Minor, Jr W. in Methods in Enzymology. (eds. Carter Jr, C. W. & Sweet, R. M.) Part A, 307-326 (Academic Press, 1997).
66. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
67. Brunger, A. T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (1998).
68. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
69. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
70. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291 (1993).